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Summary
The HIF-1 transcription factor drives hypoxic gene expression changes that are thought to be adaptive for cells exposed to
a reduced-oxygen environment. For example, HIF-1 induces the expression of glycolytic genes. It is presumed that increased
glycolysis is necessary to produce energy when low oxygen will not support oxidative phosphorylation at the mitochondria.
However, we find that while HIF-1 stimulates glycolysis, it also actively represses mitochondrial function and oxygen con-
sumption by inducing pyruvate dehydrogenase kinase 1 (PDK1). PDK1 phosphorylates and inhibits pyruvate dehydrogenase
from using pyruvate to fuel the mitochondrial TCA cycle. This causes a drop in mitochondrial oxygen consumption and re-
sults in a relative increase in intracellular oxygen tension. We show by genetic means that HIF-1-dependent block to oxygen
utilization results in increased oxygen availability, decreased cell death when total oxygen is limiting, and reduced cell death
in response to the hypoxic cytotoxin tirapazamine.Introduction
Tissue hypoxia results when supply of oxygen from the blood-
stream does not meet demand from the cells in the tissue.
Such a supply-demand mismatch can occur in physiologic con-
ditions such as the exercising muscle, in the pathologic condi-
tion such as the ischemic heart, or in the tumor microenviron-
ment (Hockel and Vaupel, 2001; Semenza, 2004). In either the
physiologic circumstance or pathologic conditions, there is a
molecular response from the cell in which a program of gene ex-
pression changes is initiated by the hypoxia-inducible factor-1
(HIF-1) transcription factor. This program of gene expression
changes is thought to help the cells adapt to the stressful envi-
ronment. For example, HIF-1-dependent expression of erythro-
poietin and angiogenic compounds results in increased blood
vessel formation for delivery of a richer supply of oxygenated
blood to the hypoxic tissue. Additionally, HIF-1 induction of gly-
colytic enzymes allows for production of energy when the mito-
chondria are starved of oxygen as a substrate for oxidative
phosphorylation. We now find that this metabolic adaptation is
more complex, with HIF-1 not only regulating the supply of ox-
ygen from the bloodstream, but also actively regulating the ox-
ygen demand of the tissue by reducing the activity of the major
cellular consumer of oxygen, the mitochondria.
Perhaps the best-studied example of chronic hypoxia is the
hypoxia associated with the tumor microenvironment (Brown
and Giaccia, 1998). The tumor suffers from poor oxygen supply
through a chaotic jumble of blood vessels that are unable to ad-
equately perfuse the tumor cells. The oxygen tension within the
tumor is also a function of the demand within the tissue, with ox-
ygen consumption influencing the extent of tumor hypoxia (Gul-
ledge andDewhirst, 1996; Papandreou et al., 2005b). The net re-
sult is that a large fraction of the tumor cells are hypoxic. Oxygen
tensions within the tumor range from near normal at the capillary
wall, to near zero in the perinecrotic regions. This perfusion-lim-CELL METABOLISM 3, 187–197, MARCH 2006 ª2006 ELSEVIER INC.ited hypoxia is a potent microenvironmental stress during tumor
evolution (Graeber et al., 1996; Hockel and Vaupel, 2001) and an
important variable capable of predicting for poor patient out-
come. (Brizel et al., 1996; Cairns and Hill, 2004; Hockel et al.,
1996; Nordsmark and Overgaard, 2004).
The HIF-1 transcription factor was first identified based on its
ability to activate the erythropoetin gene in response to hypoxia
(Wang and Semenza, 1993). Since then, it is has been shown to
be activated by hypoxia in many cells and tissues, where it can
induce hypoxia-responsive target genes such as VEGF and
Glut1 (Airley et al., 2001; Kimura et al., 2004). The connection be-
tween HIF-regulation and human cancer was directly linked
when it was discovered that the VHL tumor suppressor gene
was part of the molecular complex responsible for the oxic deg-
radation of HIF-1a (Maxwell et al., 1999). In normoxia, a family of
prolyl hydroxylase enzymes uses molecular oxygen as a sub-
strate and modifies HIF-1a and HIF2a by hydroxylation of pro-
lines 564 and 402 (Bruick and McKnight, 2001; Epstein et al.,
2001). VHL then recognizes the modified HIF-a proteins, acts
as an E3-type of ubiquitin ligase, and along with elongins B
and C is responsible for the polyubiquitination of HIF-as and
their proteosomal degradation (Bruick and McKnight, 2001;
Chan et al., 2002; Ivan et al., 2001; Jaakkola et al., 2001). Muta-
tions in VHL lead to constitutive HIF-1 gene expression, and pre-
dispose humans to cancer. The ability to recognize modified
HIF-as is at least partly responsible for VHL activity as a tumor
suppressor, as introduction of nondegradable HIF-2a is capable
of overcoming the growth–inhibitory activity of wild-type (wt)
VHL in renal cancer cells (Kondo et al., 2003).
Mitochondrial function can be regulated by PDK1 expression.
Mitochondrial oxidative phosphorylation (OXPHOS) is regulated
by several mechanisms, including substrate availability (Brown,
1992). The major substrates for OXPHOS are oxygen, which is
the terminal electron acceptor, and pyruvate, which is the pri-
mary carbon source. Pyruvate is the end product of glycolysisDOI 10.1016/j.cmet.2006.01.012 187
A R T I C L Eand is converted to acetyl-CoA through the activity of the pyru-
vate dehydrogenase complex of enzymes. The acetyl-CoA then
directly enters the TCA cycle at citrate synthase where it is com-
bined with oxaloacetate to generate citrate. In metazoans, the
conversion of pyruvate to acetyl-CoA is irreversible and there-
fore represents a critical regulatory point in cellular energy me-
tabolism. Pyruvate dehydrogenase is regulated by three known
mechanisms: it is inhibited by acetyl-CoA and NADH, it is stim-
ulated by reduced energy in the cell, and it is inhibited by regu-
latory phosphorylation of its E1 subunit by pyruvate dehydroge-
nase kinase (PDK) (Holness and Sugden, 2003; Sugden and
Holness, 2003). There are fourmembers of the PDK family in ver-
tebrates, each with specific tissue distributions (Roche et al.,
2001). PDK expression has been observed in human tumor bi-
opsies (Koukourakis et al., 2005), and we have reported that
PDK3 is hypoxia-inducible in some cell types (Denko et al.,
2003). In this manuscript, we find that PDK1 is also a hypoxia-
responsive protein that actively regulates the function of the mi-
tochondria under hypoxic conditions by reducing pyruvate entry
into the TCA cycle. By excluding pyruvate from mitochondrial
consumption, PDK1 induction may increase the conversion of
pyruvate to lactate, which is in turn shunted to the extracellular
space, regenerating NAD for continued glycolysis.
Results
Identification of HIF-dependent mitochondrial proteins
through genomic and bioinformatics approaches
In order to help elucidate the role of HIF-1a in regulating metab-
olism, we undertook a genomic search for genes that were reg-
ulated by HIF-1 in tumor cells exposed to hypoxia in vitro. We
used genetically matched human RCC4 cells that had lost
VHL during tumorigenesis and displayed constitutive HIF-1 ac-
tivity, and a cell line engineered to re-express VHL to establish
hypoxia-dependent HIF activation. These cells were treated
with 18 hr of stringent hypoxia (<0.01% oxygen), and microarray
analysis performed. Using a strict 2.5-fold elevation as our cut-
off, we identified 173 genes that were regulated by hypoxia and/
or VHL status (Table S1 in the Supplemental Data available with
this article online). We used the pattern of expression in these
experiments to identify putative HIF-regulated genes—ones
that were constitutively elevated in the parent RCC4s indepen-
dent of hypoxia, downregulated in the RCC4VHL cells under
normoxia, and elevated in response to hypoxia. Of the 173 hyp-
oxia and VHL-regulated genes, 74 fit the putative HIF-1 target
pattern. The open reading frames of these genes were run
through a pair of bioinformatics engines in order to predict sub-
cellular localization, and 10 proteins scored as mitochondrial on
at least one engine. The genes, fold induction, and mitochon-
drial scores are listed in Table 1.
HIF-1 downregulates mitochondrial
oxygen consumption
Having identified several putative HIF-1 responsive gene prod-
ucts that had the potential to regulate mitochondrial function,
we then directly measured mitochondrial oxygen consumption
in cells exposed to long-term hypoxia. While other groups
have studiedmitochondrial function under acute hypoxia (Chan-
del et al., 1997), this is one of the first descriptions of mitochon-
drial function after long-term hypoxia where there have been ex-
tensive hypoxia-induced gene expression changes. Figure 1A is188an example of the primary oxygen trace from a Clark electrode
showing a drop in oxygen concentration in cell suspensions of
primary fibroblasts taken from normoxic and hypoxic cultures.
The slope of the curve is a direct measure of the total cellular ox-
ygen consumption rate. Exposure of either primary human or
immortalized mouse fibroblasts to 24 hr of hypoxia resulted in
a reduction of this rate by approximately 50% (Figures 1A and
1B). In these experiments, the oxygen consumption can be stim-
ulated with the mitochondrial uncoupling agent CCCP (carbonyl
cyanide 3-chloro phenylhydrazone) and was completely in-
hibited by 2 mM potassium cyanide. We determined that the
change in total cellular oxygen consumption was due to
changes in mitochondrial activity by the use of the cell-perme-
able poison of mitochondrial complex 3, Antimycin A. Figure 1C
shows that the difference in the normoxic and hypoxic oxygen
consumption in murine fibroblasts is entirely due to the Antimy-
cin-sensitive mitochondrial consumption. The kinetics with
which mitochondrial function slows in hypoxic tumor cells also
suggests that it is due to gene expression changes because it
takes over 6 hr to achieve maximal reduction, and the reversal
of this repression requires at least another 6 hr of reoxygenation
(Figure 1D). These effects are not likely due to proliferation or
toxicity of the treatments as these conditions are not growth in-
hibitory or toxic to the cells (Papandreou et al., 2005a).
Since we had predicted from the gene expression data that
the mitochondrial oxygen consumption changes were due to
HIF-1-mediated expression changes, we tested several geneti-
cally matched systems to determine what role HIF-1 played in
the process (Figure 2). We first tested the cell lines that had
been used for microarray analysis and found that the parental
RCC4 cells had reduced mitochondrial oxygen consumption
when compared to the VHL-reintroduced cells. Oxygen con-
sumption in the parental cells was insensitive to hypoxia, while
it was reduced by hypoxia in the wild-type VHL-transfected
cell lines. Interestingly, stable introduction of a tumor-derived
mutant VHL (Y98H) that cannot degrade HIF was also unable
to restore oxygen consumption. These results indicate that
increased expression of HIF-1 is sufficient to reduce oxygen
consumption (Figure 2A). We also investigated whether HIF-1
Table 1. Identification of putative HIF-1a-regulated mitochondrial proteins
through microarray, bioinformatics, and data-mining approaches
Gene Identifier Ind 1 Ind 2 Loc 1 Loc 2
SLC9A6 Na/H exchanger 6 AF030409 13.0 19.0 M Mit
GPT2 Glut/pyr transaminase AY029173 10.0 10.0 M C/Mit
MCG45806 (Rab 39-like) Hs.55272 13.0 19.0 2 Mit
BNIP3 E1B 19 kD-interacting
protein 3
AF002697 9.1 4.3 2 Mem Mit
PPP1R3C protein
phosphatase 1 3C
BC012625 7.3 6.9 M C
AP1G1 Adaptor-related
complex 1 1
Y12226 3.5 3.2 M C
PDK1 Pyruvate
dehydrogenase kin 1
L42450 3.1 5.9 M Mit
Hypothetical protein FLJ36666 AK093985 2.9 9.0 2 Mit
PFKFB4 phosphofructo-2
kinase 4
BC010269 2.6 2.6 2 Mit
PTPN14 Protein tyr
phosphotase
BC017300 2.5 3.0 M Mem Mit
Ind 1 and 2 represent the fold induction for the indicated gene based on the two
microarray experiments, Loc1 is the predicted subcellular location based on Tar-
getP V1.0 (www.cbs.dtu.dk), and Loc2 is the predicted subcellular localization
based on ProtComp V6.0 (www.softberry.com).CELL METABOLISM : MARCH 2006
HIF1 regulation of mitochondrial functionFigure 1. Hypoxia inhibits mitochondrial oxygen
consumption
A) Oxygen concentration curves generated using
a Clark electrode for fibroblast suspensions from cul-
tures exposed to normoxia or hypoxia for 24 hr. Ar-
rows indicate addition of the mitochondrial uncou-
pler CCCP and cytochrome poison cyanide. The
slope of the curve is a measure of the rate of oxygen
consumption.
B) Average oxygen consumption rates in normal hu-
man fibroblasts and immortalized murine fibroblasts
cultured in normoxia or 0.5% O2 for 24 hr.
C) Fraction of total oxygen consumption due to mito-
chondrial versus nonmitochondrial consumption in
wild-type murine fibroblasts. Mitochondrial con-
sumption was determined using 1ug/ml of the cell
permeable complex 3 inhibitor Antimycin A.
D) Change in oxygen consumption in RKO cells after
exposure to the indicated time in 0.5% O2, and time
to recovery in normoxia following 24 hr hypoxia.
For all graphs, the error bars represent the standard
error of the mean.induction was required for the observed reduction in oxygen
consumption in hypoxia using two genetically matched sys-
tems. We measured normoxic and hypoxic oxygen consump-
tion in murine fibroblasts derived from wild-type or HIF-1a null
embryos (Figure 2B) and from human RKO tumor cells and
RKO cells constitutively expressing ShRNAs directed against
the HIF-1a gene (Figures 2C and 4C). Neither of the HIF-defi-
cient cell systemswas able to reduce oxygen consumption in re-
sponse to hypoxia. These data from the HIF-overexpressing
RCC cells and the HIF-deficient cells indicate that HIF-1 is
both necessary and sufficient for reducing mitochondrial oxy-
gen consumption in hypoxia.
HIF-dependent mitochondrial changes are functional,
not structural
Because addition of CCCP could increase oxygen consumption
even in the hypoxia-treated cells, we hypothesized that the hyp-
oxic inhibition was a regulated activity, not a structural change in
the mitochondria in response to hypoxic stress. We confirmed
this interpretation by examining several additional mitochondrial
characteristics in hypoxic cells such as mitochondrial morphol-
ogy, quantity, and membrane potential. We examined morphol-CELL METABOLISM : MARCH 2006ogy by visual inspection of both the transiently transfected mito-
chondrially localized DsRed protein and the endogenous
mitochondrial protein cytochrome C. Both markers were indis-
tinguishable in the parental RCC4 and the RCC4VHL cells
(Figure 3A). Likewise, we measured the mitochondrial mem-
brane potential with the functional dye rhodamine 123 and found
that it was identical in the matched RCC4 cells and the matched
HIF wt and knockout (KO) cells when cultured in normoxia or
hypoxia (Figure 3B). Finally, we determined that the quantity of
mitochondria per cell was not altered in response to HIF or hyp-
oxia by showing that the amount of the mitochondrial marker
protein HSP60 was identical in the RCC4 and HIF cell lines
(Figure 3C)
PDK1 is a HIF-1 inducible target protein
After examination of the list of putative HIF-regulated mitochon-
drial target genes, we hypothesized that PDK1 could mediate
the functional changes that we observed in hypoxia. We there-
fore investigated PDK1 protein expression in response to HIF
and hypoxia in the genetically matched cell systems. Figure 4A
shows that in the RCC4 cells PDK1 and the HIF-target gene
BNip3 (Greijer et al., 2005; Papandreou et al., 2005a) were189
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expression of PDK1 inversely matching the oxygen consump-
tion measured in Figure 1 above. Likewise, the HIF wt MEFs
show oxygen-dependent induction of PDK1 and BNip3, while
the HIF KOMEFs did not show any expression of either of these
proteins under any oxygen conditions (Figure 4B). Finally, the
parental RKO cells were able to induce PDK1 and the HIF target
gene BNip3L in response to hypoxia, while the HIF-depleted
ShRNA RKO cells could not induce either protein (Figure 4C).
Therefore, in all three cell types, the HIF-1-dependent regulation
of oxygen consumption seen in Figure 2, corresponds to the
HIF-1-dependent induction of PDK1 seen in Figure 4.
In order to determine if PDK1 was a direct HIF-1 target gene,
we analyzed the genomic sequence flanking the 50 end of the
gene for possible HIF-1 binding sites based on the consensus
core HRE element (A/G)CGTG (Caro, 2001). Several such sites
exist within the first 400 bases upstream, so we generated re-
porter constructs by fusing the genomic sequence from 2400
to +30 of the start site of transcription to the firefly luciferase
gene. In transfection experiments, the chimeric construct
showed significant induction by either cotransfectionwith a con-
stitutively active HIF proline mutant (P402A/P564G) (Chan et al.,
2002) or exposure of the transfected cells to 0.5% oxygen
(Figure 4D). Most noteworthy, when the reporter gene was
transfected into the HIF-1a null cells, it did not show induction
Figure 2. Hypoxic reduction in mitochondrial oxygen consumption is HIF-1 de-
pendent
A) Average oxygen consumption rates in vhl-deficient RCC4 cells, RCC4/VHL
cells, and RCC4/VHLY98H cells after exposure to 24 hr of normoxia or 0.5% O2.
B) Average oxygen consumption rates in HIF wt and HIF KO murine fibroblasts af-
ter exposure to normoxia or 0.5% O2 for 24 hr.
C) Average oxygen consumption rates in parental RKO cells and ShRNAHIF-1a
RKO cells after exposure to 24 hr of normoxia or 0.5% O2.
For all graphs, the error bars represent the standard error of the mean.190when the cells were cultured in hypoxia, but it did show induc-
tion when cotransfected with expression HIF-1a plasmid. We
then generated deletions down to the first 36 bases upstream
Figure 3. Mitochondria are not grossly altered by hypoxia or HIF activity
A) Fluorescent microscopy of RCC4 and RCC4/VHL cells under normoxic condi-
tions shows no morphologic difference in mitochondria. In the top panels, cells
were transiently transfected with mito-DsRed to label mitochondria and visualized
with 594 nm excitation. In the bottom panels, immunofluorescence was used to vi-
sualize the endogenous mitochondrial protein cytochrome c and detected with
anti-mouse Alexa 488 secondary antibody.
B) Mitochondrial membrane potential is not altered in RCC4, RCC4/VHL, RCC4/
VHLY98H, HIF wt MEFs, and HIF KO MEFs after exposure to normoxia or 0.5%
O2 for 24 hr. Rhodamine 123 staining and flow cytometry was used to measure
themean fluorescence intensity, which is expressed relative to parental cells under
normoxic conditions.
C)Western blot of lysates from the indicated cells exposed to normoxia or 0.5%O2
for 24 hr were probed for mitochondrial HSP60, a constitutive mitochondrial pro-
tein, as a measure of total mitochondrial mass. Blots were reprobed for tubulin as
a loading control.
For all graphs, the error bars represent the standard error of the mean.CELL METABOLISM : MARCH 2006
HIF1 regulation of mitochondrial functionFigure 4. PDK1 protein is upregulated by hypoxia in a HIF-dependent manner
A) Western blots of RCC4, RCC4/VHL, and RCC4/VHLY98H lysates after expo-
sure to normoxia or 0.5% O2 for 24 hr. Blots were probed for HIF 1a, PDK1, the
HIF target gene BNip3, and tubulin as a loading control.
B)Western blots of HIF wt and HIF KOMEF lysates after exposure to the indicated
oxygen concentrations for 24 hr. Blots were probed for PDK1, the HIF target gene
BNip3, and tubulin as a loading control.
C)Western blots of ShRNABNip3RKO and ShRNAHIF-1aRKO lysates after expo-
sure to normoxia or 0.5% O2 for 24 hr. Blots were probed for HIF 1a, to demon-
strate specific inhibition in the ShHIF 1a cell line, PDK1, the HIF target gene
BNip3L, and tubulin as a loading control. Note that BNip3 is not expressed in
RKO cells.
D) Analysis of the PDK1 promoter for functional HREs. Segments of DNA taken
from the indicated 50-flanking region were fused to the firefly luciferase gene andCELL METABOLISM : MARCH 2006of transcription and found that even this short sequence was re-
sponsive to HIF-1 (Figure 4D). Analysis of this small fragment
showed only one consensus HRE site located in an inverted ori-
entation in the 50 untranslated region. We synthesized and
cloned a mutant promoter fragment in which the core element
ACGTG was replaced with AAAAG, and this construct lost over
90% of its hypoxic induction. These experiments suggest that
it is this HREwithin the proximal 50 UTR that HIF-1 uses to trans-
activate the endogenous PDK1 gene in response to hypoxia.
PDK1 is responsible for the HIF-dependent
mitochondrial oxygen consumption changes
In order to directly test if PDK1 was the HIF-1 target gene re-
sponsible for the hypoxic reduction in mitochondrial oxygen
consumption, we generated RKO cell lines with either knock-
down or overexpression of PDK1 and measured the oxygen
consumption in these derivatives. The PDK1 ShRNA stable
knockdown line was generated as a pool of clones cotrans-
fected with pSUPER ShPDK1 and pTK-hygro resistance gene.
After selection for growth in hygromycin, the cells were tested
by Western blot for the level of PDK1 protein expression. We
found that normoxic PDK1 is reduced by 75%, however, there
was measurable expression of PDK1 in these cells in response
to hypoxia (Figure 5A). When we measured the corresponding
oxygen consumption in these cells, we found a change com-
mensurate with the level of PDK1. The knockdown cells show el-
evated baseline oxygen consumption, and partial reduction in
this activity in response to hypoxia. Therefore, reduction of
PDK1 expression by geneticmeans increasedmitochondrial ox-
ygen consumption in both normoxic and hypoxic conditions. In-
terestingly, these cells still induced HIF-1a (Figure 5A) and HIF-1
target genes such as BNip3L in response to hypoxia (data not
shown), suggesting that altered PDK1 levels do not alter HIF-
1a function.
We also determined if overexpression of PDK1 could lead to
reduced mitochondrial oxygen consumption. A separate culture
of RKO cells was transfected with a PDK1-IRES-puro expres-
sion plasmid and selected for resistance to puromycin. The
pool of puromycin resistant cells was tested for PDK1 expres-
sion by Western blot. These cells showed a modest increase
in PDK1 expression under control conditions when compared
to the cells transfected with GUS-IRES-puro, with an additional
increase in PDK1 protein in response to hypoxia (Figure 5C). The
corresponding oxygen consumption measurements showed
that the mitochondria is very sensitive to changes in the levels
of PDK1, as even this slight increase was able to significantly re-
duce oxygen consumption in the normoxic PDK1-puro cultures.
Further increase in PDK1 levels with hypoxia further reduced ox-
ygen consumption in both cultures (Figure 5D). The model de-
scribing the relationship between hypoxia, HIF-1, PDK1, and in-
termediate metabolism is described in Figure 5E.
transiently transfected into the wild-type and the HIF1a knockout cells as indi-
cated. Cells were either cotransfected with 50 ng of empty vector or HIF1a
(P402A/P564G) expression plasmid, or they were treated with 24 hr 0.5% hypoxia
as indicated. The relative luciferase activity wasmeasured in a Beckton Dickenson
Monolite 2000 and normalized for transfection efficiency using cotransfected re-
nilla luciferase and empty pGL3 for a noninducible construct. The baseline expres-
sion of the reporter genes is within 2-fold when comparing normoxic HIF wt to HIF
KO cells. Note the loss of HIF-dependent induction in the 236 to +30 fragment
when the target HRE is mutated.
For all graphs, the error bars represent the standard error of the mean.191
A R T I C L EFigure 5. PDK1 expression directly regulates cellu-
lar oxygen consumption rate
A) Western blot of RKO cell and ShRNAPDK1RKO
cell lysates after exposure to 24 hr of normoxia or
0.5% O2. Blots were probed for HIF 1a, PDK1, and
tubulin as a loading control.
B) Oxygen consumption rate in RKO and
ShRNAPDK1RKO cells after exposure to 24 hr of
normoxia or 0.5% O2.
C) Western blot of RKOiresGUS cell and RKOir-
esPDK1 cell lysates after exposure to 24 hr of nor-
moxia or 0.5% O2. Blots were probed for HIF 1a,
PDK1, and tubulin as a loading control.
D) Oxygen consumption rate in RKOiresGUS and
RKOiresPDK1 cells after exposure to 24 hr of nor-
moxia or 0.5% O2.
E) Model describing the interconnected effects of
HIF-1 target gene activation on hypoxic cell metabo-
lism. Reduced oxygen conditions causes HIF-1 to
coordinately induce the enzymes shown in boxes.
HIF-1 activation results in increased glucose trans-
porter expression to increase intracellular glucose
flux, induction of glycolytic enzymes increases the
conversion of glucose to pyruvate generating energy
and NADH, induction of PDK1 decreases mitochon-
drial utilization of pyruvate and oxygen, and induc-
tion of LDH increases the removal of excess pyruvate
as lactate and also regenerates NAD+ for increased
glycolysis.
For all graphs, the error bars represent the standard
error of the mean.Altering oxygen consumption alters intracellular oxygen
tension and sensitivity to hypoxia-dependent cell killing
The intracellular concentration of oxygen is a net result of the
rate at which oxygen diffuses into the cell and the rate at which
it is consumed. We hypothesized that the rate at which oxygen
was consumed within the cell would significantly affect its
steady-state intracellular concentrations. We tested this hy-
pothesis in vitro using the hypoxic marker drug pimonidazole
(Bennewith and Durand, 2004). We plated high density cultures
of HIF wild-type and HIF knockout cells and placed these cul-
tures in normoxic, 2% oxygen, and anoxic incubators for over-
night treatment. The overnight treatment gives the cells time
to adapt to the hypoxic conditions and establish altered oxygen
consumption profiles. Pimonidozole was then added for the last
4 hr of the growth of the culture. Pimonidazole binding was de-192tected after fixation of the cells using an FITC labeled anti-pimo-
nidazole antibody and it was quantitated by flow cytometry. The
quantity of the bound drug is a direct indication of the oxygen
concentration within the cell (Bennewith and Durand, 2004).
The histograms in Figure 6A show that the HIF-1 knockout
and wild-type cells show similar staining in the cells grown in
0% oxygen. However, the cells treated with 2% oxygen show
the consequence of the genetic removal of HIF-1. The HIF-pro-
ficient cells showed relatively less pimonidazole binding at 2%
when compared to the 0% culture, while the HIF-deficient cells
showed identical binding between the cells at 2% and those at
0%. We interpret these results to mean that the HIF-deficient
cells have greater oxygen consumption, and this has lowered
the intracellular oxygenation from the ambient 2% to close
to zero intracellularly. The HIF-proficient cells reduced theirCELL METABOLISM : MARCH 2006
HIF1 regulation of mitochondrial functionFigure 6. HIF-dependent decrease in oxygen con-
sumption raises intracellular oxygen concentration,
protects when oxygen is limiting, and decreases sen-
sitivity to tirapazamine in vitro
A) Pimonidazole was used to determine the intracel-
lular oxygen concentration of cells in culture. HIF wt
and HIF KOMEFswere grown at high density and ex-
posed to 2% O2 or anoxia for 24 hr in glass dishes.
For the last 4 hr of treatment, cells were exposed to
60 mg/ml pimonidazole. Pimonidazole binding was
quantitated by flow cytometry after binding of an
FITC conjugated anti-pimo mAb. Results are repre-
sentative of two independent experiments.
B) HIF1a reduces oxygen consumption and protects
cells when total oxygen is limited. HIF wt and HIF KO
cells were plated at high density and sealed in alumi-
num jigs at <0.02% oxygen. At the indicated times,
cells were harvested, and dead cells were quanti-
tated by trypan blue exclusion. Note both cell lines
are equally sensitive to anoxia-induced apoptosis,
so the death of the HIF null cells indicates that the in-
creased oxygen consumption removed any residual
oxygen in the jig and resulted in anoxia-induced
death.
C) PDK1 is responsible for HIF-1’s adaptive re-
sponse when oxygen is limiting. A similar jig experi-
ment was performed to measure survival in the pa-
rental RKO, the RKO ShRNAHIF1a, and the
RKOShPDK1 cells. Cell death by trypan blue uptake
was measured 48 hr after the jigs were sealed.
D) HIF status alters sensitivity to TPZ in vitro. HIF wt
and HIF KOMEFswere grown at high density in glass
dishes and exposed to 21%, 2%, and <0.01% O2
conditions for 18 hr in the presence of varying con-
centrations of Tirapazamine. After exposure, cells
were harvested and replated under normoxia to de-
termine clonogenic viability. Survival is calculated
relative to the plating efficiency of cells exposed to
0 mM TPZ for each oxygen concentration.
E) Cell density alters sensitivity to TPZ. HIF wt and
HIF KO MEFs were grown at varying cell densities
in glass dishes and exposed to 2% O2 in the pres-
ence of 10 mM TPZ for 18 hr. After the exposure, sur-
vival was determined as described in (C).
For all graphs, the error bars represent the standard
error of the mean.oxygen consumption rate so that the rate of diffusion into the cell
is greater than the rate of consumption.
HIF-induced PDK1 can reduce the total amount of oxygen
consumed per cell. The reduction in the amount of oxygen con-
sumed could be significant if there is a finite amount of oxygen
available, as would be the case in the hours following a blood
vessel occlusion. The tissue that is fed by the vessel would ben-
efit from being economical with the oxygen that is present. We
experimentally modeled such an event using aluminum jigs
that could be sealed with defined amounts of cells and oxygen
present (Siim et al., 1996). We placed 10 3 106 wild-type or
HIF null cells in the sealed jig at 0.02% oxygen, waited for the
cells to consume the remaining oxygen, and measured cell via-
bility. We have previously shown that these two cell types are re-
sistant to mild hypoxia and equally sensitive to anoxia-induced
apoptosis (Papandreou et al., 2005a). Therefore, any death in
this experiment would be the result of the cells consuming the
small amount of remaining oxygen and dying in response to an-CELL METABOLISM : MARCH 2006oxia. We found that in sealed jigs, the wild-type cells are more
able to adapt to the limited oxygen supply by reducing con-
sumption. The HIF null cells continued to consume oxygen,
reached anoxic levels, and started to lose viability within 36 hr
(Figure 6B). This is a secondary adaptive effect of HIF1. We con-
firmed that PDK1was responsible for this difference by perform-
ing a similar experiment using the parental RKO cells, the
RKOShRNAHIF1a and the RKOShRNAPDK1 cells. We found
similar results in which both the cells with HIF1a knockdown
and PDK1 knockdown were sensitive to the long-term effects
of being sealed in a jig with a defined amount of oxygen (Fig-
ure 6c). Note that the RKOShPDK1 cells are evenmore sensitive
than the RKOShHIF1a cells, presumably because they have
higher basal oxygen consumption rates (Figure 5B).
Because HIF-1 can help cells adapt to hypoxia and maintain
some intracellular oxygen level, it may also protect tumor cells
from killing by the hypoxic cytotoxin tirapazamine (TPZ). TPZ
toxicity is very oxygen dependent, especially at oxygen levels193
A R T I C L Ebetween 1%–4% (Koch, 1993). We therefore tested the relative
sensitivity of the HIF wt and HIF KO cells to TPZ killing in high
density cultures (Figure 6D). We exposed the cells to the indi-
cated concentrations of drug and oxygen concentrations over-
night. The cells were then harvested and replated to determine
reproductive viability by colony formation. Both cell types
were equally resistant to TPZ at 21% oxygen, while both cell
types are equally sensitive to TPZ in anoxic conditions where in-
tracellular oxygen levels are equivalent (Figure 6A). The identical
sensitivity of both cell types in anoxia indicates that both cell
types are equally competent in repairing the TPZ-induced
DNA damage that is presumed to be responsible for its toxicity.
However, in 2% oxygen cultures, the HIF null cells displayed
a significantly greater sensitivity to the drug than the wild-type
cells. This suggests that the increased oxygen consumption
rate in the HIF-deficient cells is sufficient to lower the intracellu-
lar oxygen concentration relative to that in the HIF-proficient
cells. The lower oxygen level is significant enough to dramati-
cally sensitize these cells to killing by TPZ.
If the increased sensitivity to TPZ in the HIF ko cells is deter-
mined by intracellular oxygen consumption differences, then
this effect should also be cell-density dependent. We showed
that this is indeed the case in Figure 6E where oxygen and
TPZ concentrations were held constant, and increased cell den-
sity lead to increased TPZ toxicity. The effect was much more
pronounced in the HIF KO cells, although the HIF wt cells
showed some increased toxicity in the highest density cultures,
consistent with the fact they were still consuming some oxygen,
even with HIF present (Figure 1). The in vitro TPZ survival data is
therefore consistent with our hypothesis that control of oxygen
consumption can regulate intracellular oxygen concentration,
and suggests that increased oxygen consumption could sensi-
tize cells to hypoxia-dependent therapy.
Discussion
The findings presented here show that HIF-1 is actively respon-
sible for regulating energy production in hypoxic cells by an ad-
ditional, previously unrecognized mechanism. It has been
shown that HIF-1 induces the enzymes responsible for glycoly-
sis when it was presumed that low oxygen did not support effi-
cient oxidative phosphorylation (Iyer et al., 1998; Seagroves
et al., 2001). The use of glucose to generate ATP is capable of
satisfying the energy requirements of a cell if glucose is in ex-
cess (Papandreou et al., 2005a). We now find that at the same
time that glycolysis is increasing, mitochondrial respiration is
decreasing. However, the decreased respiration is not because
there is not enough oxygen present to act as a substrate for ox-
idative phosphorylation, but because the flow of pyruvate into
the TCA cycle has been reduced by the activity of pyruvate de-
hydrogenase kinase. Other reports have suggested that oxygen
utilization is shifted in cells exposed to hypoxia, but these re-
ports have focused on other regulators such as nitric oxide syn-
thase (Hagen et al., 2003). NO can reduce oxygen consumption
through direct inhibition of cytochrome oxidase, but this effect
seems to be more significant at physiologic oxygen concentra-
tions, not at severe levels seen in the tumor (Palacios-Callender
et al., 2004).
Several reports have also suggested a link between altered
mitochondrial function in hypoxia and HIF activation (Brunelle
et al., 2005; Guzy et al., 2005; Mansfield et al., 2005). While194the models are not mutually exclusive, our results indicate that
HIF target gene activation is upstream of mitochondrial function,
and responsible for altering mitochondrial activity. The question
becomes more complicated with the acute (biochemical) and
chronic (epigenetic) changes that occur with different kinetics.
In fact, there may be several levels of adaptive response and
feedback-feedforward cycles such as the recently reported
downregulation of succinate dehydrogenase by hypoxia (Dahia
et al., 2005).
This hypoxic shift in intermediate metabolism away from oxi-
dative phosphorylation provides an elegant means for the cell to
maintain both energy and redox states (diagrammed in Figure 5)
(Semenza et al., 2001). ATP is produced through the breakdown
of glucose to pyruvate but requires NAD as a cofactor for glyc-
eraldehyde phosphate dehydrogenase (GAPDH), where it is re-
duced into NADH. NADH is routinely oxidized by the mitochon-
dria to produce high energy electrons for electron chain transfer
and is regenerated to NAD for glycolysis. Under anoxic condi-
tions, NADH is not recycled by the mitochondria, and so it
must be regenerated by another means. The alternative nonoxy-
gen requiring pathway is through the conversion of pyruvate to
lactate by lactate dehydrogenase (LDH). Lactate is secreted
into the extracellular space, and NAD is regenerated. The NAD
cycle and redox state of the cell is therefore maintained through
the activity of several interrelated systems, all of which are coor-
dinately regulated by HIF-1 (glycolytic enzymes, pyruvate dehy-
drogenase kinase, and lactate dehydrogenase) (Leong et al.,
2003).
Inhibiting HIF-1 activity in the hypoxic tumor cells is predicted
to have several therapeutic effects. One primary rationale for tar-
geting HIF-1 is that it should only be activated within the hypoxic
tumor, so that therapy directed against HIF should not have sys-
temic side effects. Current tumor models suggest that inhibiting
HIF target genes such as VEGF will reduce tumor angiogenesis
(Moeller et al., 2004). However, the data supporting HIF inhibi-
tion as a means for direct tumor toxicity are mixed, and it ap-
pears that a HIF inhibitor will probably not be curative on its
own. It is therefore imperative to determine what would be the
most effective combination of drugs to use with a HIF inhibitor.
We propose that one result of HIF inhibition would be to increase
oxygen consumption andmake tumorsmore hypoxic. HIF inhib-
itors might therefore be best used in clinical practice in conjunc-
tion with hypoxic cytotoxins such as Tirapazamine.
Experimental procedures
Cell lines and cell culture
Primary human fibroblasts have been described (Denko et al., 2003) and
RKO human colon carcinoma cells were obtained from the American Type
Culture Collection (ATCC, Manassas, VA). RCC4, RCC4/VHL, and RCC4/
Y98H human renal cell carcinoma cell lines have also been described previ-
ously (Chan et al., 2005). Wild-type and HIF-1a knockout mouse embryo fi-
broblasts (MEFs) were a gift from Dr. R Johnson (University of California,
San Diego). All cells were grown in Dulbecco’s Modified Eagle’s Media
(DMEM) supplemented with 10% fetal bovine serum (FBS). For moderate
hypoxia, cell culture dishes were placed into an Invivo2 humidified hypoxia
workstation (Ruskinn Technologies, Bridgend, UK) at the indicated oxygen
concentrations. Severe hypoxia was generated in an anaerobic workstation
with a palladium catalyst (Sheldon Co., Cornelius, OR). Tirapazamine (a gift of
M. Brown, Stanford University) toxicity was measured in cells after overnight
growth at the indicated density in glass dishes. The next day, fresh media
was added containing the indicated concentration of TPZ, and the cellsCELL METABOLISM : MARCH 2006
HIF1 regulation of mitochondrial functionplaced in the indicated oxygen environment. Eighteen hours later, the cells
were trypsinized, counted, and plated for colony formation in normoxia.
Plasmids and siRNAs
Full-length human PDK1 cDNA was obtained from the mammalian gene col-
lection (MGC), through the ATCC, and was cloned into pEF2aIRESpuro cre-
ating pPDK1IRESpuro. pDsRed2-mito was constructed by cloning a 28
amino acid mitochondrial targeting sequence from human cytochrome c ox-
idase subunit VIII into the pDsRed2-N1 vector (Clontech, Mountain View,
CA). For knockdown experiments, the target sequences used were: HIF-
1a, UGAGGAAGUACCAUUAUAU and PDK1, CGACACAAUGAUGUCAU
UCCCACAA. For construction of stable knockdown cell lines, the sequences
listed above were cloned into pSUPER using synthetic 64-mer oligonucleo-
tides (Brummelkamp et al., 2002). RKO/shPDK1 and RKO/shHIF-1a stable
knockdown cells were created by cotransfecting RKO cells with pTKhygro,
and either empty pSuper, pSuper-shPDK1 or pSuper-shHIF-1a (1:20 ratio)
using Lipofectamine (Invitrogen, Carlsbad, CA), followed by selection in
500 ug/ml hygromycin. The RKOPDK1IRESpuro stable overexpressing cell
lines were established by transfecting RKO cells with pPDK1IRESpuro using
Lipofectamine followed by culture in 2 mg/ml puromycin.
Microarray analysis
Total RNA was extracted using TriZol reagent (Invitrogen). Preparation of
cDNA and cRNAwas conducted following instructions in the Affymetrix Gen-
eChip Expression Analysis Manual (Affymetrix, Santa Clara, CA). cRNA was
hybridized to an oligo-based array, washed and scanned according to stan-
dard Affymetrix protocols. Data from the scanning of the Affymetrix Gene-
Chips was gathered using the Affymetrix Microarray Suite v4.0 and exported
to Microsoft Excel.
Oxygen consumption measurements
Cells were trypsinized and suspended at 3 3 106 to 6 3 106 cells per ml in
normoxic DMEM + 10% FBS. Oxygen consumption was measured in a 0.5
ml volume using an Oxytherm electrode unit (Hansatech, Norfolk, UK). This
system employs a Clark-type oxygen electrode to monitor the dissolved ox-
ygen concentration in a sealed measurement chamber over time. The data
are exported to a computerized chart recorder (Oxygraph 1.01, Hansatech,
Norfolk, UK), which calculates the rate of oxygen consumption. A small stir
bar maintains the cells in suspension, and a peltier heating block maintains
the temperature at 37ºC. Since the electrode consumes oxygen during mea-
surement, the rate of oxygen drop in 0.5 ml of DMEMmedia without cells was
established and subtracted from the total oxygen consumption rates for the
cell suspensions.
Western blotting
In brief, treated cells were harvested directly in RIPA buffer containing prote-
ase inhibitors, protein concentrations were quantitated, 25–50 mg were elec-
trophoresed on a reducing Tris-Tricine gel, and electroblotted to PVDFmem-
brane. Antibodies used were murine a-HIF-1 Transduction Labs (1:1000),
rabbit a-PDK1 Stressgen (1:2000), murine a-a tubulin Research Diagnostics
(1:2000) goat a-HSP60 Santa Cruz (1:2000), and rabbit a-Bnip3 and aBnip3L
were described previously (1:500) (Papandreou et al., 2005a). Primary anti-
bodies were detected with species-specific secondary antibodies labeled
with Alkaline Phosphatase (Vector labs 1:3000) and visualized with ECF
(Amersham) on a Storm 860 phosphoimager (Molecular Devices).
Mitochondrial membrane potential staining and flow cytometry
Rhodamine 123 (R123) (Molecular Probes, Eugene, OR) uptake was used to
measure mitochondrial membrane potential. Cells were trypsinized,
counted, and suspended at 5 3 105 cells per ml in DMEM + 10% FBS with
10 mg/ml R123, at 37ºC for 10 min. The cells were pelleted by centrifugation
and resuspended in cold DMEM + 10% FBS. Fluorescence was measured in
a FACSCalibur flow cytometer (Becton Dickinson, San Jose, CA). Forward
scatter and side scatter values were used to gate on whole cells, and R123
fluorescence was measured for 10,000 cells per sample using the FL2 chan-
nel. All gain and amplifier settings were held constant for the duration of the
experiment. Since the R123 fluorescence values for all samples displayed
a log normal distribution, the geometric mean was used as a quantitative
measure of the cell population’s membrane potential.CELL METABOLISM : MARCH 2006Immunocytochemistry and fluorescence microscopy
Cells were plated on glass multiwell chamber slides (Nalge Nunc, Naperville,
IL) in DMEM + 10% FBS. For examination of mitochondrial DsRed2, cells
were transfected using Lipofectamine, 48 hr later they were fixed in 4%para-
formaldehyde, and mounted in Vectashield (Vector Laboratories, Burlin-
game, CA). For cytochrome c immunocytochemistry, chamber slides were
fixed in 4% paraformaldehyde, blocked in PBS Tween milk (0.2% Tween
20, 5% nonfat dry milk, in PBS) overnight at 4 C. Cytochrome c was visual-
ized using a mouse monoclonal antibody 1:250 (BD Pharmingen, San Diego,
CA) and an anti-mouse Alexa 488 secondary antibody 1:500 (Molecular
Probes). Cells were visualized on a Nikon Eclipse E800 microscope, with
a Spot RT Slider CCD digital camera using standard FITC and Texas Red fil-
ter blocks (Diagnostic Instruments, Sterling Heights, MI).
Pimonidazole staining
Hypoxyprobe 1 (pimonidazole hydrochloride) was purchased from Chem-
icon (Temecula, CA). Cells were treated at 60 mg/liter in the culture medium
during the final 4 hr of the hypoxic exposure, harvested, fixed in 4% parafor-
maldehyde, blocked in PBS containing 5% nonfat dry milk and 0.1%Triton
and 4% FBS (PBS-T-milk-FBS). After 2 hr blocking, cells were treated with
FITC-labeled anti-pimonidozole mAb at 1:25 dilution for 2 hr in PBS-T-
milk-FBS. The cells were then washed in PBS-T-milk-FBS and relative
FITC was measured on FL1 in a Beckton-Dickenson FacScanner.
Data analysis
Oxygen consumption experiments were repeated three times in duplicate,
survival was measured three times in triplicate, reporter assays were re-
peated two times in quadruplicate. Error bars represent the standard error
of the mean.
Supplemental data
Supplemental data include one table and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/3/3/187/DC1/.
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